Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)
Trulieve Cannabis (TRLV) reported Q3 2026 revenue of $230M, up 4% YoY, driven by growth in Georgia and Pennsylvania. The company exceeded guidance and posted net income of $1M. Management highlighted expansion plans and federal tax milestones. TRLV shares rose 6.06% to $11.56 on Nov 8, 2026.
How this was made
The 30-second read
Why it matters
The earnings beat provides a fresh data point for valuation models and may trigger short covering.
Market read
Earnings exceed expectations, offering a short‑term trading edge for TRLV.
What to watch
Potential regulatory changes in other states could affect future growth.
Background
Trulieve recently listed on NYSE and has been expanding in Georgia and Pennsylvania.
Ticker impact
Trulieve Cannabis Corp. reported Q3 revenue of $230M (up 4%) and net income of $1M, exceeding guidance.
likely upward pressure as market prices in the revenue beat
The company posted better-than-expected revenue and profit, providing a fresh catalyst for traders.
Market effects
May lift sentiment for other multi‑state cannabis operators.
Positive for U.S. cannabis sector, especially Georgia and Pennsylvania markets.
Limited to cannabis industry investors.
Counterpoint
Despite the beat, the modest profit margin and high valuation could limit upside.
Key entities
- companyTrulieve Cannabis Corp.
U.S. multi‑state cannabis operator.
